Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase

In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archiv der Pharmazie (Weinheim) 2003-03, Vol.336 (1), p.31-38
Hauptverfasser: Baston, Eckhard, Salem, Ola I. A., Hartmann, Rolf W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 38
container_issue 1
container_start_page 31
container_title Archiv der Pharmazie (Weinheim)
container_volume 336
creator Baston, Eckhard
Salem, Ola I. A.
Hartmann, Rolf W.
description In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.
doi_str_mv 10.1002/ardp.200390001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73143313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73143313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</originalsourceid><addsrcrecordid>eNqFkE1vEzEQhi0EoqFw5Yh8gdsGjz92u9zSUJqiqqDyebO89iwxOOtg75bkZ_FH-E1slKjlxmmk0fO-M3oIeQpsCozxlya59ZQzJmrGGNwjE1AcCgkn8j6ZMFGqouRCHJFHOX8fCcG4ekiOgJdlyRVMSJxvbYhL3BRQYId0blITN9vgLZ1Z7_Ir-mHb9UvMPlPTOXrqY4jfvDWBnt2YMJjex47Gll7FGwz0olv6xvcx5d1uMaxMR9Wf3_Qa3WB7k_ExedCakPHJYR6TT2_OPs4XxeW784v57LKwUtZQGHAABiQqhQYrK3lZsdaZRvITgFZw10hZcoeibpoK2xoaYWzreM25tMqIY_Ji37tO8eeAudcrny2GYDqMQ9aVACkEiBGc7kGbYs4JW71OfmXSVgPTO8V6p1jfKh4Dzw7NQ7NCd4cfnI7A8wNg8uipTaazPt9xslRMsnrk6j33ywfc_uesnl2_fv_vE8U-63OPm9usST90WYlK6S9X51ou2Ff29nOlpfgLpoulHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73143313</pqid></control><display><type>article</type><title>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Baston, Eckhard ; Salem, Ola I. A. ; Hartmann, Rolf W.</creator><creatorcontrib>Baston, Eckhard ; Salem, Ola I. A. ; Hartmann, Rolf W.</creatorcontrib><description>In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.</description><identifier>ISSN: 0365-6233</identifier><identifier>EISSN: 1521-4184</identifier><identifier>DOI: 10.1002/ardp.200390001</identifier><identifier>PMID: 12666251</identifier><identifier>CODEN: ARPMAS</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>5-alpha Reductase Inhibitors ; Benign prostatic hyperplasia ; Biological and medical sciences ; Carboxylic Acids - chemical synthesis ; Carboxylic Acids - chemistry ; Carboxylic Acids - pharmacology ; Chromatography, High Pressure Liquid ; Cyclohex-1-ene carboxylic acids ; DU 145 cells ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Humans ; Isoenzymes - drug effects ; Isozymes 1 and 2 ; Male ; Medical sciences ; Nonsteroidal inhibitors ; Pharmacology. Drug treatments ; Steroid 5α reductase ; Steroidomimetics ; Structure-Activity Relationship ; Urinary system</subject><ispartof>Archiv der Pharmazie (Weinheim), 2003-03, Vol.336 (1), p.31-38</ispartof><rights>2003 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</citedby><cites>FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fardp.200390001$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fardp.200390001$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14650409$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12666251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baston, Eckhard</creatorcontrib><creatorcontrib>Salem, Ola I. A.</creatorcontrib><creatorcontrib>Hartmann, Rolf W.</creatorcontrib><title>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</title><title>Archiv der Pharmazie (Weinheim)</title><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><description>In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.</description><subject>5-alpha Reductase Inhibitors</subject><subject>Benign prostatic hyperplasia</subject><subject>Biological and medical sciences</subject><subject>Carboxylic Acids - chemical synthesis</subject><subject>Carboxylic Acids - chemistry</subject><subject>Carboxylic Acids - pharmacology</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cyclohex-1-ene carboxylic acids</subject><subject>DU 145 cells</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Isoenzymes - drug effects</subject><subject>Isozymes 1 and 2</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nonsteroidal inhibitors</subject><subject>Pharmacology. Drug treatments</subject><subject>Steroid 5α reductase</subject><subject>Steroidomimetics</subject><subject>Structure-Activity Relationship</subject><subject>Urinary system</subject><issn>0365-6233</issn><issn>1521-4184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1vEzEQhi0EoqFw5Yh8gdsGjz92u9zSUJqiqqDyebO89iwxOOtg75bkZ_FH-E1slKjlxmmk0fO-M3oIeQpsCozxlya59ZQzJmrGGNwjE1AcCgkn8j6ZMFGqouRCHJFHOX8fCcG4ekiOgJdlyRVMSJxvbYhL3BRQYId0blITN9vgLZ1Z7_Ir-mHb9UvMPlPTOXrqY4jfvDWBnt2YMJjex47Gll7FGwz0olv6xvcx5d1uMaxMR9Wf3_Qa3WB7k_ExedCakPHJYR6TT2_OPs4XxeW784v57LKwUtZQGHAABiQqhQYrK3lZsdaZRvITgFZw10hZcoeibpoK2xoaYWzreM25tMqIY_Ji37tO8eeAudcrny2GYDqMQ9aVACkEiBGc7kGbYs4JW71OfmXSVgPTO8V6p1jfKh4Dzw7NQ7NCd4cfnI7A8wNg8uipTaazPt9xslRMsnrk6j33ywfc_uesnl2_fv_vE8U-63OPm9usST90WYlK6S9X51ou2Ff29nOlpfgLpoulHg</recordid><startdate>200303</startdate><enddate>200303</enddate><creator>Baston, Eckhard</creator><creator>Salem, Ola I. A.</creator><creator>Hartmann, Rolf W.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley-VCH</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200303</creationdate><title>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</title><author>Baston, Eckhard ; Salem, Ola I. A. ; Hartmann, Rolf W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4491-a1d11a14e55eae7c42670fdab42811f32db4462de39bb7ef91b3acfd29224c5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>5-alpha Reductase Inhibitors</topic><topic>Benign prostatic hyperplasia</topic><topic>Biological and medical sciences</topic><topic>Carboxylic Acids - chemical synthesis</topic><topic>Carboxylic Acids - chemistry</topic><topic>Carboxylic Acids - pharmacology</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cyclohex-1-ene carboxylic acids</topic><topic>DU 145 cells</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Isoenzymes - drug effects</topic><topic>Isozymes 1 and 2</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nonsteroidal inhibitors</topic><topic>Pharmacology. Drug treatments</topic><topic>Steroid 5α reductase</topic><topic>Steroidomimetics</topic><topic>Structure-Activity Relationship</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baston, Eckhard</creatorcontrib><creatorcontrib>Salem, Ola I. A.</creatorcontrib><creatorcontrib>Hartmann, Rolf W.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archiv der Pharmazie (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baston, Eckhard</au><au>Salem, Ola I. A.</au><au>Hartmann, Rolf W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase</atitle><jtitle>Archiv der Pharmazie (Weinheim)</jtitle><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><date>2003-03</date><risdate>2003</risdate><volume>336</volume><issue>1</issue><spage>31</spage><epage>38</epage><pages>31-38</pages><issn>0365-6233</issn><eissn>1521-4184</eissn><coden>ARPMAS</coden><abstract>In search of novel nonsteroidal mimics of steroidal inhibitors of 5α reductase, 4‐(2‐phenylethyl)cyclohex‐1‐ene carboxylic acids 1—5 were synthesized with different substituents in para position of the phenyl ring (1: N, N‐diisopropylcarbamoyl, 2: phenyl, 3: phenoxy, 4: benzoyl, and 5: benzyl). The principal synthetic approach for the desired compounds consisted of a Wittig olefination between 1, 4‐dioxaspiro [4.5]‐decane‐8‐carbaldehyde (4g and the appropriate phosphonium salts. The compounds were tested for inhibition of human 5α reductase isozymes 1 and 2 using DU 145 cells and preparations from prostatic tissue, respectively. They turned out to be good inhibitors of the prostatic isozyme 2 with compound 1 being the most potent one (IC50 = 760 nM). Isozyme 1 was only slightly inhibited. It is concluded that the novel structures are appropriate for being further optimized, aiming at the development of a novel drug for the treatment of benign prostatic hyperplasia.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>12666251</pmid><doi>10.1002/ardp.200390001</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0365-6233
ispartof Archiv der Pharmazie (Weinheim), 2003-03, Vol.336 (1), p.31-38
issn 0365-6233
1521-4184
language eng
recordid cdi_proquest_miscellaneous_73143313
source MEDLINE; Wiley Online Library All Journals
subjects 5-alpha Reductase Inhibitors
Benign prostatic hyperplasia
Biological and medical sciences
Carboxylic Acids - chemical synthesis
Carboxylic Acids - chemistry
Carboxylic Acids - pharmacology
Chromatography, High Pressure Liquid
Cyclohex-1-ene carboxylic acids
DU 145 cells
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Humans
Isoenzymes - drug effects
Isozymes 1 and 2
Male
Medical sciences
Nonsteroidal inhibitors
Pharmacology. Drug treatments
Steroid 5α reductase
Steroidomimetics
Structure-Activity Relationship
Urinary system
title Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A34%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclohex-1-ene%20Carboxylic%20Acids:%20Synthesis%20and%20Biological%20Evaluation%20of%20Novel%20Inhibitors%20of%20Human%205%CE%B1%20Reductase&rft.jtitle=Archiv%20der%20Pharmazie%20(Weinheim)&rft.au=Baston,%20Eckhard&rft.date=2003-03&rft.volume=336&rft.issue=1&rft.spage=31&rft.epage=38&rft.pages=31-38&rft.issn=0365-6233&rft.eissn=1521-4184&rft.coden=ARPMAS&rft_id=info:doi/10.1002/ardp.200390001&rft_dat=%3Cproquest_cross%3E73143313%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73143313&rft_id=info:pmid/12666251&rfr_iscdi=true